Cerus (CERS) EBIT Growth (3y) (2013 - 2026)
Cerus (CERS) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 13.06% |
| 10 | Cerus | 562.58 Mn | 506.32 Mn | 29.53 Mn | -27.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.75% |
| Mar 31, 2026 | 70.75% |
| Dec 31, 2025 | 59.91% |
| Sep 30, 2025 | 29.39% |
| Jun 30, 2025 | 20.59% |
| Mar 31, 2025 | 15.92% |
| Dec 31, 2024 | 40.74% |
| Sep 30, 2024 | 55.80% |
| Jun 30, 2024 | 35.66% |
| Mar 31, 2024 | 21.42% |
| Dec 31, 2023 | 27.41% |
| Sep 30, 2023 | 27.89% |
| Jun 30, 2023 | 7.29% |
| Mar 31, 2023 | 2.80% |
| Dec 31, 2022 | 15.35% |
| Sep 30, 2022 | 23.99% |
| Jun 30, 2022 | 25.89% |
| Mar 31, 2022 | 15.06% |
| Dec 31, 2021 | 23.35% |
| Sep 30, 2021 | 6.48% |